CRP and neoplasm: Additionally, no correlation was found between biomarkers’ plasma levels and factors such as C-reactive protein (CRP), neutrophil to lymphocyte ratio (NLR), tumor PD-L1 expression, and nivolumab levels regardless sampling occasion (Supplementary Table S2).